Key result
Maternal administration of oral flecainide successfully normalized fetal heart rate to 120-130 bpm and resolved early hydrops fetalis in a fetus with supraventricular tachycardia.
Why the study?
Fetal arrhythmia can lead to hydrops fetalis and fetal heart failure if untreated.
Does maternal administration of flecainide resolve fetal SVT and early hydrops fetalis?
Case Report (n=1)
No
Does maternal administration of flecainide resolve fetal SVT and early hydrops fetalis?
Maternal administration of flecainide successfully treated fetal SVT complicated by early hydrops fetalis, leading to the delivery of a healthy infant.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for flecainide in fetal SVT with hydrops; prospective trials needed before clinical adoption.
Fetal arrhythmia that can lead to hydrops fetalis and fetal heart failure if untreated. This case report describes the successful treatment of a fetus with SVT at 26 weeks of gestation using flecainide. A 37‐year‐old gravida 3, para 2 woman was diagnosed with fetal SVT during a routine ultrasound, which also revealed mild pleural effusion, pericardial effusion, and ascites, raising concerns for hydrops fetalis. A fetal echocardiogram confirmed a heart rate of 250–300 beats per minute with preserved cardiac function. The mother was started on oral flecainide at 100 mg twice daily, which was increased to 150 mg twice daily after 3 days due to persistent fetal tachycardia. Within 24 h of the dosage adjustment, the fetal heart rate normalized to 120–130 beats per minute, and the hydrops resolved by the third week of treatment. The mother delivered a healthy baby at 39 weeks, and the infant has remained free of SVT episodes to date. This case demonstrates the efficacy and safety of flecainide in treating fetal SVT, particularly in cases complicated by early hydrops.
No takes yet. Share an insight, caveat, or question.
Faridpour et al. (2026) conducted a case report in Fetal Supraventricular Tachycardia (n=1). Flecainide was evaluated on Fetal heart rate normalization and hydrops resolution. Maternal administration of oral flecainide successfully normalized fetal heart rate to 120-130 bpm and resolved early hydrops fetalis in a fetus with supraventricular tachycardia.
Synapse has enriched 10 related papers. Consider them for comparative context: